Masoud Toloue - Revvity VP Diagnostics

RVTY Stock   126.84  3.32  2.69%   

VP

Masoud Toloue is VP Diagnostics of Revvity
Age 44
Address 940 Winter Street, Waltham, MA, United States, 02451
Phone781 663 6900
Webhttps://www.revvity.com

Masoud Toloue Latest Insider Activity

Tracking and analyzing the buying and selling activities of Masoud Toloue against Revvity stock is an integral part of due diligence when investing in Revvity. Masoud Toloue insider activity provides valuable insight into whether Revvity is net buyers or sellers over its current business cycle. Note, Revvity insiders must abide by specific rules, including filing SEC forms every time they buy or sell Revvity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Revvity Management Efficiency

The company has return on total asset (ROA) of 0.0172 % which means that it generated a profit of $0.0172 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0331 %, meaning that it created $0.0331 on every $100 dollars invested by stockholders. Revvity's management efficiency ratios could be used to measure how well Revvity manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Revvity's Return On Assets are fairly stable compared to the past year. Return On Equity is likely to rise to 0.12 in 2025, whereas Return On Tangible Assets are likely to drop 0.08 in 2025. At this time, Revvity's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 12.8 B in 2025, whereas Net Tangible Assets are likely to drop (2.3 B) in 2025.

Similar Executives

Showing other executives

VP Age

Sandra JDLaboratory of
65
Keeley JDWaters
48
Eric JDIQVIA Holdings
61
Simon MayAgilent Technologies
53
Gina MullaneCharles River Laboratories
N/A
Robert WernerTwist Bioscience Corp
52
Dennis ChoTwist Bioscience Corp
53
Matthew DanielCharles River Laboratories
N/A
Bret DiMarcoAgilent Technologies
57
John GilardiQiagen NV
N/A
Matthew JDCharles River Laboratories
N/A
Kerri JosephIQVIA Holdings
N/A
Sharon JDIDEXX Laboratories
64
Diana ChiuAgilent Technologies
N/A
Dennis JDTwist Bioscience Corp
54
Jenipher DaltonAgilent Technologies
N/A
Jeffrey MDIQVIA Holdings
N/A
Keriann CherofskyIQVIA Holdings
40
John MoylanNeogen
N/A
Deborah SesokPizziniLaboratory of
N/A
Marcia EisenbergLaboratory of
65
Revvity (RVTY) is traded on New York Stock Exchange in USA. It is located in 940 Winter Street, Waltham, MA, United States, 02451 and employs 11,000 people. Revvity is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Revvity Leadership Team

Elected by the shareholders, the Revvity's board of directors comprises two types of representatives: Revvity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Revvity. The board's role is to monitor Revvity's management team and ensure that shareholders' interests are well served. Revvity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Revvity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joel Goldberg, General Administration
Jayashree Thacker, Senior Officer
Madhuri FACMG, Senior Officer
Bryan Kipp, Senior Licensing
Andrew Okun, Chief VP
Miriame Victor, Senior Officer
Magali Four, Senior Officer
Stephen Willoughby, Senior ESG
Tajinder Vohra, Senior Operations
Prahlad Singh, President CEO
Robert Friel, Advisor
Maxwell Krakowiak, Senior CFO
Masoud Toloue, VP Diagnostics
Daniel Tereau, Senior Development
Arvind SundarRajan, Vice Technology

Revvity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Revvity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revvity Stock Analysis

When running Revvity's price analysis, check to measure Revvity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revvity is operating at the current time. Most of Revvity's value examination focuses on studying past and present price action to predict the probability of Revvity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revvity's price. Additionally, you may evaluate how the addition of Revvity to your portfolios can decrease your overall portfolio volatility.